Literatur
Nach Informationen von Novartis
Author information
Consortia
Rights and permissions
About this article
Cite this article
Urban & Vogel. EU-Zulassung für Canakinumab bei SJIA. Pädiatrie 25, 446 (2013). https://doi.org/10.1007/s15014-013-0278-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15014-013-0278-z